Kostbar Pharma Private Limited
About Kostbar Pharma Private Limited
Data last updated:
Kostbar Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the management consultancy activity segment of the professional services sector. It was incorporated on 24 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74140DL2015PTC284501.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajeev Kumar Tyagi and Vipin Tyagi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khasra No. 122 Land Mark Opp Madhban Market Village – Wa, Zirabad, New Delhi, Delhi, India – 110084.
As per the financials filed for FY 2025, the company reported a revenue of ₹35,000. For the same year it recorded a net profit of ₹33,841 (net margin 96.7%) and EBITDA of ₹33,841 (EBITDA margin 96.7%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKhasra No. 122 Land Mark Opp Madhban Market Village – Wa, Zirabad, New Delhi, Delhi, India – 110084
- IndustryProfessional Services, Management Consultancy Activity, Tax Consultant, Accounting
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Kostbar Pharma Private Limited FY 2025 filings available
Kostbar Pharma Private Limited reported revenue of ₹35,000 for FY 2025.
Financial Statement Summary of Kostbar Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹33,841 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹33,841 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kostbar Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 96.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 96.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kostbar Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Kostbar Pharma Private Limited
Kostbar Pharma Private Limited is audited by SURBHI BANSAL for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SURBHI BANSAL | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Kostbar Pharma Private Limited
Kostbar Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Kumar Tyagi | Director | 24 Aug 2015 | 11 Years 1 Months | Current |
| Vipin Tyagi | Director | 24 Aug 2015 | 11 Years 1 Months | Current |
Ownership and Shareholding of Kostbar Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kostbar Pharma Private Limited
Kostbar Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Kostbar Pharma Private Limited
Employment history and EPFO contributions of people linked to Kostbar Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kostbar Pharma Private Limited
Kostbar Pharma Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Rajeev Kumar Tyagi was appointed as Director on 24 Aug 2015.
Credit Ratings, Litigation & Regulatory Alerts for Kostbar Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kostbar Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kostbar Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kostbar Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kostbar Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kostbar Pharma Private Limited
Kostbar Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in management consultancy activity, within the professional services industry. It was incorporated on 24 August 2015 (11+ years old) and is registered under CIN U74140DL2015PTC284501.
Kostbar Pharma reported revenue of ₹35,000 for FY 2025.
Kostbar Pharma has 2 current directors:
- Rajeev Kumar Tyagi - Director
- Vipin Tyagi - Director
Kostbar Pharma reported a net profit of ₹33,841 (net margin 96.7%) and EBITDA of ₹33,841 (EBITDA margin 96.7%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Kostbar Pharma is U74140DL2015PTC284501. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kostbar Pharma was incorporated on 24 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Rajeev Kumar Tyagi was appointed as Director on 24 Aug 2015. Vipin Tyagi was appointed as Director on 24 Aug 2015.
The registered office of Kostbar Pharma is at Khasra No. 122 Land Mark Opp Madhban Market Village – Wa, Zirabad, New Delhi, Delhi, India – 110084.
Kostbar Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Kostbar Pharma operates in the professional services industry, in the management consultancy activity segment.